However, SCGB2A2 sensitivity is limited particularly for detecting triple-negative breast cancer; moreover, it has been reported to be present in female reproductive tract tumors such as cervix, endometrium, ovary as well as certain salivary gland tumors and skin cancer. This evidence concerns the gene SCGB2A2 and triple-negative breast carcinoma.